The Catalent Applied Drug Delivery Institute has announced Jim Spavins to their advisory board.

He has over 36 years of industry and academic experience and served as the senior vice president of Pfizer’s Global Pharma Therapeutics Pharmaceutical Sciences group before starting his own consulting business, Spavins Consulting LLC.

He holds a bachelor’s degree in chemistry from Queens College, New York, as well as a Master of Arts degree in analytical chemistry, and a Master of Science degree in chemical engineering, both from University of Buffalo, New York.

He worked across large and small R&D groups within all the technical disciplines of chemistry, manufacturing and controls (CMC) development, as well as regulatory, quality, clinical supply, commercial manufacture, and economic analysis.

Spavins said, “I look forward to working with the CADDI Board to help rapidly advance innovative drug delivery solutions to patients. There has never been a more exciting time to leverage astonishing scientific advances in disease understanding with optimum delivery technology.”

Dr. Cornell Stamoran, Founder of the Catalent Applied Drug Delivery Institute and Catalent’s VP Strategy said, “I’m very pleased to welcome Jim to the Institute. He brings us a wealth of scientific and leadership experience, front line exposure to translational drug delivery, and a strong passion to enhance patient focus during drug development.”

.